Cargando…
What Is Direct Allorecognition?
Direct allorecognition is the process by which donor-derived major histocompatibility complex (MHC)-peptide complexes, typically presented by donor-derived ‘passenger’ dendritic cells, are recognised directly by recipient T cells. In this review, we discuss the two principle theories which have been...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107184/ https://www.ncbi.nlm.nih.gov/pubmed/27909647 http://dx.doi.org/10.1007/s40472-016-0115-8 |
_version_ | 1782467170415935488 |
---|---|
author | Boardman, Dominic A. Jacob, Jacinta Smyth, Lesley A. Lombardi, Giovanna Lechler, Robert I. |
author_facet | Boardman, Dominic A. Jacob, Jacinta Smyth, Lesley A. Lombardi, Giovanna Lechler, Robert I. |
author_sort | Boardman, Dominic A. |
collection | PubMed |
description | Direct allorecognition is the process by which donor-derived major histocompatibility complex (MHC)-peptide complexes, typically presented by donor-derived ‘passenger’ dendritic cells, are recognised directly by recipient T cells. In this review, we discuss the two principle theories which have been proposed to explain why individuals possess a high-precursor frequency of T cells with direct allospecificity and how self-restricted T cells recognise allogeneic MHC-peptide complexes. These theories, both of which are supported by functional and structural data, suggest that T cells recognising allogeneic MHC-peptide complexes focus either on the allopeptides bound to the allo-MHC molecules or the allo-MHC molecules themselves. We discuss how direct alloimmune responses may be sustained long term, the consequences of this for graft outcome and highlight novel strategies which are currently being investigated as a potential means of reducing rejection mediated through this pathway. |
format | Online Article Text |
id | pubmed-5107184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-51071842016-11-29 What Is Direct Allorecognition? Boardman, Dominic A. Jacob, Jacinta Smyth, Lesley A. Lombardi, Giovanna Lechler, Robert I. Curr Transplant Rep Immunology (R Fairchild, Section Editor) Direct allorecognition is the process by which donor-derived major histocompatibility complex (MHC)-peptide complexes, typically presented by donor-derived ‘passenger’ dendritic cells, are recognised directly by recipient T cells. In this review, we discuss the two principle theories which have been proposed to explain why individuals possess a high-precursor frequency of T cells with direct allospecificity and how self-restricted T cells recognise allogeneic MHC-peptide complexes. These theories, both of which are supported by functional and structural data, suggest that T cells recognising allogeneic MHC-peptide complexes focus either on the allopeptides bound to the allo-MHC molecules or the allo-MHC molecules themselves. We discuss how direct alloimmune responses may be sustained long term, the consequences of this for graft outcome and highlight novel strategies which are currently being investigated as a potential means of reducing rejection mediated through this pathway. Springer International Publishing 2016-10-07 2016 /pmc/articles/PMC5107184/ /pubmed/27909647 http://dx.doi.org/10.1007/s40472-016-0115-8 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Immunology (R Fairchild, Section Editor) Boardman, Dominic A. Jacob, Jacinta Smyth, Lesley A. Lombardi, Giovanna Lechler, Robert I. What Is Direct Allorecognition? |
title | What Is Direct Allorecognition? |
title_full | What Is Direct Allorecognition? |
title_fullStr | What Is Direct Allorecognition? |
title_full_unstemmed | What Is Direct Allorecognition? |
title_short | What Is Direct Allorecognition? |
title_sort | what is direct allorecognition? |
topic | Immunology (R Fairchild, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107184/ https://www.ncbi.nlm.nih.gov/pubmed/27909647 http://dx.doi.org/10.1007/s40472-016-0115-8 |
work_keys_str_mv | AT boardmandominica whatisdirectallorecognition AT jacobjacinta whatisdirectallorecognition AT smythlesleya whatisdirectallorecognition AT lombardigiovanna whatisdirectallorecognition AT lechlerroberti whatisdirectallorecognition |